SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Feb 8, 2021
Document Date
Feb 8, 2021
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc